Sheba Medical Center’s New COVID-19 Inspired Immersive Simulation Patient Room Uses AI, AR and Robotic Monitoring
|
By HospiMedica International staff writers Posted on 29 May 2020 |

Illustration
A new COVID-19 inspired immersive simulation patient room of the future at Sheba Medical Center (Tel HaShomer, Israel) realistically simulates extreme medical situations by combining live actors as patients and doctors, as well as robotic clinical simulators.
The strategic medical technologies for this hi-tech patient room at Sheba Medical Center, the largest and most comprehensive medical center in the Middle East, have been implemented by EarlySense (Woburn, MA, USA), a provider of contact-free, continuous monitoring solutions for the healthcare continuum. The hi-tech patient room of the future includes an array of monitoring, AI, augmented reality (AR) and robotic technologies that can be tested quickly and safely, allowing fast turn-around times for inventing, developing, testing, and demonstrating next generation technologies.
The EarlySense system has been implemented by Sheba Medical Center as well as other global healthcare facilities to continuously monitor COVID-19 patients while also protecting healthcare staff. The technology is installed in more than 40,000 patient beds in hospitals and post-acute care facilities worldwide. The contact-free continuous monitoring system tracks respiratory rate, heart rate and movement without ever touching the patient. The sensor, placed under the patient's mattress, transmits real-time patient data for the early detection of clinical changes to a display outside of the patient's room, limiting the need for staff to gown up and enter isolation areas. The EarlySense system is clinically proven to help prevent adverse events, including code blue events resulting from cardiac or respiratory arrest, patient falls, pressure ulcers, preventable ICU transfers and hospital readmissions.
"Contact-free continuous monitoring is, by nature, uniquely suited to care for COVID-19 patients. However, its value extends even further as we look toward the future of patient care and telehealth," said Matt Johnson, EarlySense CEO. "We are pleased to be included in this first-of-its-kind project, as we remain committed to assisting hundreds of healthcare facilities around the globe provide proactive, quality patient care and support."
The strategic medical technologies for this hi-tech patient room at Sheba Medical Center, the largest and most comprehensive medical center in the Middle East, have been implemented by EarlySense (Woburn, MA, USA), a provider of contact-free, continuous monitoring solutions for the healthcare continuum. The hi-tech patient room of the future includes an array of monitoring, AI, augmented reality (AR) and robotic technologies that can be tested quickly and safely, allowing fast turn-around times for inventing, developing, testing, and demonstrating next generation technologies.
The EarlySense system has been implemented by Sheba Medical Center as well as other global healthcare facilities to continuously monitor COVID-19 patients while also protecting healthcare staff. The technology is installed in more than 40,000 patient beds in hospitals and post-acute care facilities worldwide. The contact-free continuous monitoring system tracks respiratory rate, heart rate and movement without ever touching the patient. The sensor, placed under the patient's mattress, transmits real-time patient data for the early detection of clinical changes to a display outside of the patient's room, limiting the need for staff to gown up and enter isolation areas. The EarlySense system is clinically proven to help prevent adverse events, including code blue events resulting from cardiac or respiratory arrest, patient falls, pressure ulcers, preventable ICU transfers and hospital readmissions.
"Contact-free continuous monitoring is, by nature, uniquely suited to care for COVID-19 patients. However, its value extends even further as we look toward the future of patient care and telehealth," said Matt Johnson, EarlySense CEO. "We are pleased to be included in this first-of-its-kind project, as we remain committed to assisting hundreds of healthcare facilities around the globe provide proactive, quality patient care and support."
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read moreSurgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel








